Skip to main content
. 2022 Feb 17;25(6):516–519. doi: 10.4103/ijem.ijem_439_21

Table 2.

Proportion of oral glucocorticoid sale with the total drug sale (n=29)

GC sale/Total drug sale % n % 95% CI
0-1% 15 51.7 32-70%
2-5% 7 24.1 10-43%
6-10% 3 10.3 2-27%
11-20% 0 0 --
21-50% 3 10.3 2-27%
>51% 1 3.4 0.09-18%